Zakary L. Whichard

Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155

D W Lee, Muneyoshi Futami, Martin Carroll et al. · Oncogene · 2012 · 63 citations

Functional Genomics, Ship-1 Protein Expression, Medicine +12

Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias

Bella S. Guerrouahen, Muneyoshi Futami, Christos Vaklavas et al. · Clinical Cancer Research · 2010 · 47 citations · Full text

Loss of the F-BAR protein CIP4 reduces platelet production by impairing membrane-cytoskeleton remodeling

Yolande Chen, Jorie Aardema, Sayali Kale et al. · Blood · 2013 · 44 citations

Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines – Lessons for design of combination targeted therapy

Brian Park, Zakary L. Whichard, Seth J. Corey · Cancer Letters · 2012 · 41 citations · Full text

Breast Oncology, Drug Targeting, Medicine +9

G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase

Muneyoshi Futami, Quan-Sheng Zhu, Zakary L. Whichard et al. · Blood · 2011 · 39 citations · Full text